RT

RTW Biotech Opportunities Ltd

Overview

Corporate Details

ISIN(s):
GG00BKTRRM22
LEI:
549300Q7EXQQH6KF7Z84
Country:
United States of America
Address:
40 10TH AVE, 10014 NEW YORK
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

No description available.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for RTW Biotech Opportunities Ltd. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-22 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB
2025-08-19 08:01
Report Publication Announcement
Notice of Interim Results
English 13.6 KB
2025-08-19 08:00
Capital/Financing Update
Strategic Funding Agreement with Aquestive
English 15.0 KB
2025-08-15 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB
2025-08-14 08:00
Fund Information / Factsheet
Monthly Valuation Update and Factsheet
English 29.3 KB
2025-07-17 08:00
Regulatory News Service
Update on Kailera Therapeutics
English 15.4 KB
2025-07-15 08:00
Fund Information / Factsheet
Monthly Valuation Update and Factsheet
English 32.5 KB
2025-07-10 08:00
M&A Activity
Merck to acquire Verona Pharma
English 15.7 KB
2025-07-03 18:34
Major Shareholding Notification
Holding(s) in Company
English 51.0 KB
2025-03-31 08:00
Annual Report
Annual Financial Report
English 1.6 MB
2025-03-28 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB
2025-03-26 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB

Automate Your Workflow. Get a real-time feed of all RTW Biotech Opportunities Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for RTW Biotech Opportunities Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN